Skip to content

Behavioural Treatment of Hypertension

Behavioural Treatment of Hypertension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00247910
Enrollment
150
Registered
2005-11-02
Start date
2001-10-31
Completion date
2006-06-30
Last updated
2011-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

hypertension, ambulatory BP, office resting BP, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy

Brief summary

The objective of the study is to determine whether psychological therapy (self-help or individualized intense stress management) is different than a single drug treatment in terms of their effectiveness for lowering blood pressure.

Interventions

DRUGHydrochlorothiazide

Not recorded in detailed description.

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* must be at least 19 years of age * subjects can be male or female * subjects must have an average resting blood pressure of \>140 systolic pressure an/ or \>90 diastolic pressure off anti-hypertensive medication

Exclusion criteria

* must not be on more than 2 blood pressure lowering drugs * must not have known or suspected of having secondary hypertension on initial examination * must not be pregnant or anticipating pregnancy during study period * must not have history of allergy, hypersensitivity or intolerance to diuretics * must not have medical condition that may result in an unacceptable risk of complications due to uncontrolled hypertension during time period of study * must not have average resting BP readings that exceed 190 systolic, or 115 diastolic, or have two consecutive readings of 180 systolic or 110 diastolic

Design outcomes

Primary

MeasureTime frame
Day time ambulatory BPSee description

Secondary

MeasureTime frame
24 hour ambulatory BP, and office resting BPSee description

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026